Search research articles
Contact Us
Filters
Showing results (101-110 of 109) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 109 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Pharmacokinetics of an intravenous-oral versus intravenous-mesna regimen in lung cancer patients receiving ifosfamide
M P Goren, L B Anthony, K R Hande, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1986
Antiemetic effect of oral versus intravenous metoclopramide in patients receiving cisplatin: a randomized, double-blind trial
L B Anthony, M G Krozely, N J Woodward, et al.
Annals of Internal Medicine
|
October 1, 1976
Sepsis with a new species of Corynebacterium
K R Hande, F G Witebsky, M S Brown, et al.
Cancer
|
March 1, 1979
Chemotherapy prior to local therapy in advanced squamous cell carcinoma of the head and neck: Preliminary assessment of an intensive drug regimen
E G Elias, P B Chretien, E Monnard, et al.
Seminars in Oncology
|
August 1, 1997
Preliminary analysis of a phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small cell lung cancer
H Choy, R F DeVore, K R Hande, et al.
Drugs
|
July 1, 1978
Antineoplastic drugs: clinical pharmacology and therapeutic use
R A Bender, L A Zwelling, J H Doroshow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1988
Non-Hodgkin's lymphoma of the gastrointestinal tract: an analysis of clinical and pathologic features affecting outcome
A F List, J P Greer, J C Cousar, et al.
Blood
|
August 1, 1990
High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy
R A Brown, R H Herzig, S N Wolff, et al.
Cancer Chemotherapy and Pharmacology
|
November 7, 1999
Treatment of poor-prognosis extensive disease small-cell lung cancer with an all-oral regimen of etoposide and cyclophosphamide - a Southwest Oncology Group clinical and pharmacokinetic study
S M Grunberg, J Crowley, K R Hande, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 109) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 109 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 20, 1998
Pharmacokinetics of an intravenous-oral versus intravenous-mesna regimen in lung cancer patients receiving ifosfamide
M P Goren, L B Anthony, K R Hande, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1986
Antiemetic effect of oral versus intravenous metoclopramide in patients receiving cisplatin: a randomized, double-blind trial
L B Anthony, M G Krozely, N J Woodward, et al.
Annals of Internal Medicine
|
October 1, 1976
Sepsis with a new species of Corynebacterium
K R Hande, F G Witebsky, M S Brown, et al.
Cancer
|
March 1, 1979
Chemotherapy prior to local therapy in advanced squamous cell carcinoma of the head and neck: Preliminary assessment of an intensive drug regimen
E G Elias, P B Chretien, E Monnard, et al.
Seminars in Oncology
|
August 1, 1997
Preliminary analysis of a phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small cell lung cancer
H Choy, R F DeVore, K R Hande, et al.
Drugs
|
July 1, 1978
Antineoplastic drugs: clinical pharmacology and therapeutic use
R A Bender, L A Zwelling, J H Doroshow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1988
Non-Hodgkin's lymphoma of the gastrointestinal tract: an analysis of clinical and pathologic features affecting outcome
A F List, J P Greer, J C Cousar, et al.
Blood
|
August 1, 1990
High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy
R A Brown, R H Herzig, S N Wolff, et al.
Cancer Chemotherapy and Pharmacology
|
November 7, 1999
Treatment of poor-prognosis extensive disease small-cell lung cancer with an all-oral regimen of etoposide and cyclophosphamide - a Southwest Oncology Group clinical and pharmacokinetic study
S M Grunberg, J Crowley, K R Hande, et al.
Page
of 11